Robust design
Robust assay design to ensure accurate and reliable results
The World Health Organization estimates that 296 million people were living with chronic HBV infection in 2019, with 1.5 million new infections.1 HBV RNA is a promising biomarker for researchers and clinicians working to better understand HBV disease levels and progression.
cobas® HBV RNA can be used to support scientific research to understand the potential uses of this new biomarker.
cobas® HBV RNA for use on the cobas® 5800/6800/8800 Systems is an automated real-time RT-PCR assay for the in vitro quantitative detection of circulating HBV RNA in EDTA plasma and serum.
cobas® HBV RNA is intended for research use only and is not for use in diagnostic procedures.
Robust assay design to ensure accurate and reliable results
Benefit from fully automated cobas® 5800/6800/8800 Systems and an industry leading menu
Designed and optimized for use on the cobas® 5800/6800/8800 Systems, enabling absolute sample to result automation
*cobas® HBV RNA for use on the cobas® 5800/6800/8800 Systems for Research use only. Not for use in diagnostic procedures. Instructions for use. Pleasanton, CA, Roche Molecular Systems, 2022.
Research Use Only. Not for use in diagnostic procedures.
Access package inserts through your country’s Roche Diagnostics Website.
References